Chemify Unveils World's First Chemputation Facility in Glasgow, Pioneering Molecular Innovation
TL;DR
Chemify's Chemifarm offers partners a competitive edge by accelerating the discovery of small-molecule medicines and next-generation materials through AI-driven molecular design and robotic synthesis.
The Chemifarm integrates AI-driven molecular-design with industrial-scale robotic synthesis, utilizing the Chemputation platform to streamline the design, optimization, and scale-up of complex molecules.
Chemify's Chemifarm advances global health and materials science, creating jobs and fostering economic growth while tackling society's toughest challenges with innovative chemical solutions.
Discover how Chemify's Chemifarm, the world's most advanced automated chemistry facility, is revolutionizing molecular design and synthesis with AI and robotics in Glasgow.
Found this article helpful?
Share it with your network and spread the knowledge!
Chemify has officially launched the world's first Chemputation facility, known as Chemifarm, in Glasgow's Maryhill district. This 21,500-ft² site represents a leap forward in molecular design and synthesis, integrating AI-driven molecular-design with industrial-scale robotic synthesis. The facility aims to streamline the process from concept to compound, significantly speeding up the discovery of small-molecule medicines and next-generation materials.
At the heart of Chemifarm is the Chemputation platform, which includes a bespoke programming language, extensible robotics, and the world's largest library of validated reactions. This innovation enables the on-demand design, optimization, and scale-up of molecules previously considered unreachable, promising breakthroughs in drug discovery and materials science.
The £12 million project, supported by the Glasgow City Region Innovation Accelerator Programme and a £1.1M grant from Scottish Enterprise, is expected to create 60 new jobs and safeguard over 50 existing roles in Glasgow. Chemify's partners, including major pharmaceutical and biotech companies, will benefit from confidential, on-demand access to bespoke molecules for research and development.
Chemify's CEO and Founder, Lee Cronin, highlighted the facility's potential to transform molecular innovation, stating that the combination of automation, AI, and scalable synthesis allows for faster movement from code to compound. The University of Glasgow's Principal and Vice-Chancellor, Professor Sir Anton Muscatelli, also noted the significance of translating academic research into industrial innovation, emphasizing the project's impact on the regional economy and job creation.
The Chemifarm features dedicated production suites, R&D labs, and a secure cloud architecture for storing high-resolution chemical data. It will also prototype next-generation hardware for future global sites, further establishing the UK's leadership in advanced chemical and pharmaceutical industries.
Curated from Reportable
